Clinical Trial Update: The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase II study updates for icartin in advanced hepatocellular carcinoma has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Icaritin (icaritin)

Snippet

Sponsor: Beijing Shenogen Biomedical Co., Ltd | Conditions: Hepatocellular Carcinoma (HCC) | Phase 2 | Status: COMPLETED